151 related articles for article (PubMed ID: 22327928)
1. Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism.
Cakir I; Unluhizarci K; Tanriverdi F; Elbuken G; Karaca Z; Kelestimur F
Endocrine; 2012 Oct; 42(2):419-22. PubMed ID: 22327928
[TBL] [Abstract][Full Text] [Related]
2. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
3. Increased parathyroid hormone is associated with higher fasting glucose in individuals with normocalcemic primary hyperparathyroidism and prediabetes: A pilot study.
Karras SN; Koufakis T; Tsekmekidou X; Antonopoulou V; Zebekakis P; Kotsa K
Diabetes Res Clin Pract; 2020 Feb; 160():107985. PubMed ID: 31866526
[TBL] [Abstract][Full Text] [Related]
4. Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
Chen G; Xue Y; Zhang Q; Xue T; Yao J; Huang H; Liang J; Li L; Lin W; Lin L; Shi L; Cai L; Wen J
J Clin Endocrinol Metab; 2015 Jun; 100(6):2420-4. PubMed ID: 25668199
[TBL] [Abstract][Full Text] [Related]
5. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism.
Kumar S; Olukoga AO; Gordon C; Mawer EB; France M; Hosker JP; Davies M; Boulton AJ
Clin Endocrinol (Oxf); 1994 Jan; 40(1):47-53. PubMed ID: 8306480
[TBL] [Abstract][Full Text] [Related]
6. Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism.
Ayturk S; Gursoy A; Bascil Tutuncu N; Ertugrul DT; Guvener Demirag N
J Clin Endocrinol Metab; 2006 Nov; 91(11):4260-3. PubMed ID: 16895964
[TBL] [Abstract][Full Text] [Related]
7. Normocalcemic hyperparathyroidism and insulin resistance.
Temizkan S; Kocak O; Aydin K; Ozderya A; Arslan G; Yucel N; Sargin M
Endocr Pract; 2015 Jan; 21(1):23-9. PubMed ID: 25100388
[TBL] [Abstract][Full Text] [Related]
8. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients.
Yener Ozturk F; Erol S; Canat MM; Karatas S; Kuzu I; Dogan Cakir S; Altuntas Y
Endocr J; 2016; 63(2):111-8. PubMed ID: 26581584
[TBL] [Abstract][Full Text] [Related]
9. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
[TBL] [Abstract][Full Text] [Related]
10. Interplay between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism.
Gianotti L; Piovesan A; Croce CG; Pellegrino M; Baffoni C; Cesario F; Visconti G; Borretta G; Tassone F
Calcif Tissue Int; 2011 Mar; 88(3):231-7. PubMed ID: 21207016
[TBL] [Abstract][Full Text] [Related]
11. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism.
Tassone F; Procopio M; Gianotti L; Visconti G; Pia A; Terzolo M; Borretta G
Diabet Med; 2009 Oct; 26(10):968-73. PubMed ID: 19900227
[TBL] [Abstract][Full Text] [Related]
13. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.
Guo Y; Wang Q; Lu C; Fan P; Li J; Luo X; Chen D
BMC Endocr Disord; 2020 Jan; 20(1):5. PubMed ID: 31914999
[TBL] [Abstract][Full Text] [Related]
14. LOW FREE (BUT NOT TOTAL) 25-HYDROXYVITAMIN D LEVELS IN SUBJECTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM.
Wang X; Meng L; Su C; Shapses SA
Endocr Pract; 2020 Feb; 26(2):174-178. PubMed ID: 31557077
[No Abstract] [Full Text] [Related]
15. Improving Glucose Homeostasis after Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism with Co-Existing Prediabetes.
Karras S; Annweiler C; Kiortsis D; Koutelidakis I; Kotsa K
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33207657
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance is more severe in patients with primary hyperparathyroidism.
Al-Jehani A; Al-Ahmed F; Nguyen-Thi PL; Bihain F; Nomine-Criqui C; Demarquet L; Guerci B; Ziegler O; Brunaud L
Surgery; 2022 Aug; 172(2):552-558. PubMed ID: 35379519
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
[TBL] [Abstract][Full Text] [Related]
18. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
19. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.
Choi HR; Choi SH; Hong N; Rhee Y; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
J Korean Med Sci; 2022 Apr; 37(13):e99. PubMed ID: 35380024
[TBL] [Abstract][Full Text] [Related]
20. Rising Glucagon-Like Peptide 1 Concentrations After Parathyroidectomy in Patients With Primary Hyperparathyroidism.
Antonopoulou V; Karras SN; Koufakis T; Yavropoulou M; Katsiki N; Gerou S; Papavramidis T; Kotsa K
J Surg Res; 2020 Jan; 245():22-30. PubMed ID: 31400574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
